Correction to: Stem Cell Res Ther 9, 340 (2018)
https://doi.org/10.1186/s13287-018-1074-z
Following publication of the original article [1], the authors identified an editing error in Additional file 1: Fig. S1. They put the same picture in NANOG (MEIS2+/− 1#) and SOX2 (MEIS2+/− 2#) by mistake when they assembled the Fig. S1B. The heterozygous 1# and 2#, and homozygous 1# and 2# have been renamed as well.
The correct figure is given below.
Targeted deletion of MEIS2 in human hESCs. (A) Surveyor assay of sgMESI2-E3G3-mediated cleavage at MEIS2 loci in H1 hESCs. (B) Immunofluorescence analysis of OCT4, SOX2, and NANOG in undifferentiated WT, MEIS2+/−, and MEIS2−/− hESCs. Scale bar, 80 μm.
Reference
Wang, et al. Stem Cell Res Therapy. 2018;9:340.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Wang, M., Wang, H., Wen, Y. et al. Correction to: MEIS2 regulates endothelial to hematopoietic transition of human embryonic stem cells by targeting TAL1. Stem Cell Res Ther 11, 446 (2020). https://doi.org/10.1186/s13287-020-01913-2
Published:
DOI: https://doi.org/10.1186/s13287-020-01913-2